1. EULAR. (2020) Policy statement on COVID-19. Available from: https://www.eular.org/eular_guidance_for_patients_covid19_outbreak.cfm. Accessed 20 May 2020.
2. British Society for Rheumatology. (2020) COVID-19 (Coronavirus)-update for members. Available from: https://www.rheumatology.org.uk/news-policy/details/covid19-coronavirus-update-members. Accessed 25 May 2020.
3. Price E, MacPhie E, Kay L, Lanyon P, Griffiths B, Holroyd C, Abhishek A, Youngstein T, Bailey K, Clinch J, Shaikh M, Rivett A (2020) Identifying rheumatic disease patients at high risk and requiring shielding during the COVID19 pandemic. Clin Med (London, England). https://doi.org/10.7861/clinmed.2020-0160 (Published Online First: May 2020)
4. Public Health England. (2020) Guidance on shielding and protecting people defined on medical grounds as extremely vulnerable from COVID-19. Available from: https://www.gov.uk/government/publications/guidance-on-shielding-and-protecting-extremely-vulnerable-persons-from-covid-19/guidance-on-shielding-and-protecting-extremely-vulnerable-persons-from-covid-19. Accessed 25 May 2020.
5. Bateman J, Mulherin D, Hirsch G, Venkatachalam S, Sheeran T (2020) Rapid distribution of information by SMS-embedded video link to patients during a pandemic. Lancet Rheumatol. https://doi.org/10.1016/S2665-9913(20)30126-0